Renal effects: Proteinuria, hematuria.
Effects on skeletal muscle: Myalgia, myopathy, and rare rhabdomyolysis.
Liver effects: Dose-dependent elevation of transaminase.
The following adverse events have been reported with some statin therapy: Sexual dysfunction, special cases of interstitial pulmonary disease, especially those receiving long-term treatment.
Statins: 1. In the post-marketing monitoring of statins, there were reports of hyperglycemia reaction, abnormal glucose tolerance, elevated glycosylated hemoglobin level, new-onset diabetes, and deterioration of blood glucose control. Some statins also had reports of hypoglycemia reaction.
2. Post-marketing experience: In the post-marketing monitoring of statins abroad, there have been rare reports of cognitive impairment, manifested as memory loss, memory decline, thinking confusion, etc., which are mostly non-serious and reversible reactions, which can be recovered after withdrawal.
View ADR Reporting Link